Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Dow Jones Bear Market: 3 Stocks to Buy Now
09:52am, Wednesday, 05'th Oct 2022 The Motley Fool
These stocks should be big winners over the long term.
The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short
09:56pm, Monday, 03'rd Oct 2022 Benzinga
The stock market has had a rough going for the first nine months of the year in 2022. All the major indexes are down year-to-date, including the Dow Jones Industrial Average.
Here’s a look at the fo
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
09:45pm, Monday, 03'rd Oct 2022 Zacks Investment Research
Johnson & Johnson (JNJ) closed at $163.20 in the latest trading session, marking a -0.1% move from the prior day.
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
01:35pm, Monday, 03'rd Oct 2022 Zacks Investment Research
AbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new indications. They are expected to drive revenues once Humira loses U.S. exclusivity in 2023.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
10:20am, Monday, 03'rd Oct 2022 Zacks Investment Research
Smart Beta ETF report for VIG
Where to Invest $1,500 Right Now
02:45pm, Saturday, 01'st Oct 2022 The Motley Fool
Don't let a bear market environment stop you from investing in more great companies.
How To Aim For A Million Dollar Portfolio And Retire At 62
01:00pm, Saturday, 01'st Oct 2022 Seeking Alpha
Click here to read more about several strategies and model portfolios that can help you retire with a one million dollar portfolio.
2 Perfect Index Funds to Buy in a Bear Market
12:30pm, Friday, 30'th Sep 2022 The Motley Fool
These Vanguard index funds have outperformed the broader stock market over the past year.
Why This Stock's 2.7% Dividend Yield Could Be the Safest on Wall Street
10:15am, Friday, 30'th Sep 2022 The Motley Fool
It's a Dividend King with a long reign still ahead.
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
06:36pm, Thursday, 29'th Sep 2022 Benzinga
On Wednesday, Immunovant Inc (NASDAQ: IMVT) announced a new anti-FcRn, IMVT-1402, at Roivant Sciences Ltd's (NASDAQ: ROIV) Investor Day.
IMVT-1402 is a new anti-FcRn monoclonal antibody that mat
Is Johnson & Johnson a Buy?
02:37pm, Thursday, 29'th Sep 2022 The Motley Fool
The healthcare giant has been a fairly stable investment this year, but does it belong in your portfolio for the long term?
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
10:20am, Thursday, 29'th Sep 2022 Zacks Investment Research
Style Box ETF report for VTV
3 Reasons Why Cathie Wood Won't Touch This Warren Buffett Stock
09:20am, Thursday, 29'th Sep 2022 The Motley Fool
The factors keeping ARK Invest's boss away might actually be reasons to buy, depending on your needs.
Afraid of a Recession? Do These 4 Things Today
02:07pm, Wednesday, 28'th Sep 2022 The Motley Fool
Recession fears are mounting, but you don't need to be scared if you have a plan.
Here's why one strategist says the consumer and related stocks might get a second wind
02:05pm, Wednesday, 28'th Sep 2022 MarketWatch
It's a tough time for the consumer, but not all is lost, says Jefferies, which is touting some potential good news in the pipeline.
